NASDAQ : BMRN
BioMarin Pharmaceutical Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 58.51 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 11.33B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
BioMarin Pharmaceutical Inc. (BMRN) reported revenue of 3.41B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.41B | 3.22B | 2.85B | 2.42B | 2.10B | 1.85B |
| Cost of Revenue | 1.67B | 1.52B | 1.33B | 1.28B | 1.15B | 1.10B |
| Gross Profit | 1.74B | 1.70B | 1.53B | 1.14B | 943.41M | 746.97M |
| Selling, General & Admin | 1.15B | 1.03B | 1.01B | 892.41M | 823.24M | 759.38M |
| Amortization of Goodwill & Intangibles | 87.67M | 19.39M | 43.26M | 62.21M | 65.49M | 61.91M |
| Operating Expenses | 1.24B | 1.05B | 1.05B | 954.62M | 888.73M | 821.28M |
| Operating Income | 499.75M | 650.73M | 474.21M | 185.77M | 54.68M | -74.31M |
| Interest Expense | -83.61M | -10.90M | -12.67M | -17.34M | -15.97M | -15.34M |
| Interest & Investment Income | 70.10M | 74.90M | 74.88M | 58.34M | 18.03M | 10.48M |
| Currency Exchange Gain (Loss) | -11.40M | |||||
| Other Non Operating Income (Expenses) | 13.36M | 9.00M | -4.67M | -38.22M | -2.06M | 11.85M |
| EBT Excluding Unusual Items | 499.60M | 723.73M | 531.76M | 188.56M | 43.28M | -67.32M |
| Merger & Restructuring Charges | -350.49M | -241.25M | ||||
| Gain (Loss) on Sale of Assets | 10.00M | 108.00M | ||||
| Other Unusual Items | -1.70M | -8.03M | ||||
| Pretax Income | 149.11M | 482.48M | 541.76M | 188.56M | 149.58M | -75.35M |
| Income Tax Expense | 76.14M | 133.58M | 114.90M | 20.92M | 8.02M | -11.27M |
| Net Income | 72.97M | 348.90M | 426.86M | 167.65M | 141.56M | -64.08M |
| Net Income to Common | 72.97M | 348.90M | 426.86M | 167.65M | 141.56M | -64.08M |
| Shares Outstanding (Basic) | 192.55M | 191.79M | 190.03M | 187.83M | 185.27M | 182.85M |
| Shares Outstanding (Diluted) | 196.15M | 197.39M | 196.71M | 191.59M | 188.96M | 182.85M |
| EPS (Basic) | 0.38 | 1.82 | 2.25 | 0.89 | 0.76 | -0.35 |
| EPS (Diluted) | 0.38 | 1.80 | 2.21 | 0.87 | 0.75 | -0.35 |
| Free Cash Flow | 738.18M | 724.96M | 487.42M | 62.57M | 54.94M | 208.96M |
| Free Cash Flow Per Share | 3.76 | 3.67 | 2.48 | 0.33 | 0.29 | 1.14 |
| Gross Margin | 50.97% | 52.81% | 53.49% | 47.14% | 45.01% | 40.46% |
| Operating Margin | 14.67% | 20.20% | 16.62% | 7.68% | 2.61% | -4.03% |
| Profit Margin | 2.14% | 10.83% | 14.96% | 6.93% | 6.75% | -3.47% |
| Free Cash Flow Margin | 21.67% | 22.50% | 17.08% | 2.59% | 2.62% | 11.32% |
| EBITDA | 645.32M | 722.89M | 570.64M | 290.16M | 156.65M | 33.72M |
| EBITDA Margin | 18.94% | 22.44% | 19.99% | 11.99% | 7.47% | 1.83% |
| D&A For EBITDA | 145.57M | 72.16M | 96.43M | 104.39M | 101.97M | 108.04M |
| EBIT | 499.75M | 650.73M | 474.21M | 185.77M | 54.68M | -74.31M |
| EBIT Margin | 14.67% | 20.20% | 16.62% | 7.68% | 2.61% | -4.03% |
| Effective Tax Rate | 51.06% | 27.69% | 21.21% | 11.09% | 5.36% | |
| Revenue as Reported | 3.41B | 3.22B | 2.85B | 2.42B | 2.10B | 1.85B |
| Advertising Expenses | 50.50M | 34.50M | 27.80M | 25.20M | 30.20M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 874.00M | 1.31B | 942.84M | 755.13M | 724.53M | 587.28M |
| Short-Term Investments | 248.93M | 194.86M | 318.68M | 567.01M | 426.60M | |
| Cash & Short-Term Investments | 874.00M | 1.56B | 1.14B | 1.07B | 1.29B | 1.01B |
| Receivables | 1.06B | 908.21M | 660.53M | 633.70M | 461.32M | 373.40M |
| Inventory | 1.78B | 1.30B | 1.23B | 1.11B | 894.08M | 776.67M |
| Other Current Assets | 254.05M | 185.78M | 201.53M | 141.39M | 104.52M | 110.44M |
| Total Current Assets | 3.97B | 3.95B | 3.23B | 2.96B | 2.75B | 2.27B |
| Property, Plant & Equipment | 989.99M | 991.80M | 1.08B | 1.11B | 1.11B | 1.08B |
| Long-Term Investments | 492.24M | 521.24M | 622.43M | 370.33M | 524.29M | |
| Goodwill | 655.75M | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M |
| Other Intangible Assets | 4.88B | 310.84M | 320.98M | 325.30M | 338.57M | 388.65M |
| Long-Term Deferred Tax Assets | 888.58M | 1.51B | 1.49B | 1.55B | 1.51B | 1.45B |
| Other Long-Term Assets | 338.14M | 140.76M | 151.94M | 83.56M | 98.78M | 89.20M |
| Total Assets | 11.72B | 7.59B | 6.99B | 6.84B | 6.38B | 6.00B |
| Accounts Payable | 406.98M | 312.77M | 235.40M | 315.51M | 231.24M | 199.68M |
| Accrued Expenses | 526.66M | 394.31M | 331.27M | 311.55M | 293.53M | 267.65M |
| Current Portion of Long-Term Debt | 658.20M | 493.88M | ||||
| Current Portion of Leases | 16.06M | 8.69M | 7.57M | 8.78M | 10.38M | 10.46M |
| Current Income Taxes Payable | 9.14M | 3.67M | 12.57M | 2.65M | 16.21M | 1.21M |
| Current Unearned Revenue | 4.62M | 711.00K | 6.96M | |||
| Other Current Liabilities | 46.96M | 39.60M | 20.17M | 40.04M | 36.81M | 60.54M |
| Total Current Liabilities | 1.66B | 759.03M | 606.99M | 1.18B | 588.88M | 546.50M |
| Long-Term Debt | 3.53B | 597.18M | 595.14M | 593.10M | 1.08B | 1.08B |
| Long-Term Leases | 37.01M | 31.26M | 38.12M | 26.51M | 33.84M | |
| Other Long-Term Liabilities | 209.81M | 113.80M | 97.57M | 81.81M | 73.50M | 79.69M |
| Total Liabilities | 5.40B | 1.51B | 1.33B | 1.89B | 1.77B | 1.74B |
| Common Stock | 194.00K | 192.00K | 191.00K | 189.00K | 186.00K | 184.00K |
| Additional Paid-In Capital | 6.04B | 5.96B | 5.80B | 5.61B | 5.40B | 5.19B |
| Retained Earnings | 304.50M | 154.21M | -194.69M | -621.55M | -789.20M | -930.76M |
| Comprehensive Income & Other | -20.02M | -23.98M | 50.43M | -38.65M | -12.73M | 4.74M |
| Shareholders' Equity | 6.32B | 6.09B | 5.66B | 4.95B | 4.60B | 4.27B |
| Total Liabilities & Equity | 11.72B | 7.59B | 6.99B | 6.84B | 6.38B | 6.00B |
| Total Debt | 4.20B | 642.87M | 633.97M | 1.13B | 1.12B | 1.12B |
| Net Cash (Debt) | -3.33B | 917.74M | 503.74M | -60.06M | 171.63M | -109.51M |
| Net Cash Per Share | -16.97 | 4.65 | 2.56 | -0.31 | 0.91 | -0.60 |
| Filing Date Shares Outstanding | 193.57M | 192.32M | 190.78M | 188.68M | 186.53M | 184.03M |
| Total Common Shares Outstanding | 193.54M | 192.30M | 190.76M | 188.60M | 186.25M | 183.91M |
| Working Capital | 2.31B | 3.19B | 2.63B | 1.78B | 2.16B | 1.73B |
| Book Value Per Share | 32.66 | 31.65 | 29.66 | 26.25 | 24.71 | 23.19 |
| Tangible Book Value | 786.58M | 5.58B | 5.14B | 4.43B | 4.07B | 3.68B |
| Tangible Book Value Per Share | 4.06 | 29.02 | 26.95 | 23.49 | 21.84 | 20.01 |
| Land | 90.78M | 90.78M | 90.78M | 90.79M | 90.42M | |
| Buildings | 910.71M | 892.48M | 860.81M | 819.10M | 774.92M | |
| Machinery | 818.81M | 789.50M | 796.61M | 736.25M | 688.54M | |
| Construction In Progress | 134.91M | 90.27M | 100.01M | 143.38M | 136.74M | |
| Leasehold Improvements | 44.03M | 44.37M | 58.23M | 59.53M | 55.28M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 72.97M | 348.90M | 426.86M | 167.65M | 141.56M | -64.08M |
| Depreciation & Amortization | 145.57M | 72.16M | 96.43M | 104.39M | 101.97M | 108.04M |
| Other Amortization | 7.40M | 7.40M | ||||
| Loss (Gain) From Sale of Assets | -10.00M | -108.00M | ||||
| Asset Writedown & Restructuring Costs | 343.01M | 345.98M | 19.89M | 38.61M | ||
| Loss (Gain) From Sale of Investments | -4.80M | -4.80M | -8.35M | -9.23M | 3.04M | 5.16M |
| Stock-Based Compensation | 215.33M | 181.41M | 201.57M | 207.10M | 196.31M | 197.26M |
| Other Operating Activities | 138.05M | 170.61M | 62.84M | -12.71M | -62.60M | -7.88M |
| Change in Accounts Receivable | -117.94M | -228.05M | -57.91M | -190.44M | -82.03M | 65.57M |
| Change in Inventory | -32.13M | -116.93M | -63.53M | -157.06M | -68.26M | -35.06M |
| Change in Accounts Payable | 89.29M | 66.14M | -32.24M | 68.85M | 59.02M | 15.69M |
| Change in Other Net Operating Assets | 330.00K | -14.81M | -62.72M | -57.90M | -5.10M | 19.83M |
| Operating Cash Flow | 857.09M | 827.99M | 572.84M | 159.26M | 175.90M | 304.54M |
| Capital Expenditures | -118.91M | -103.04M | -85.42M | -96.69M | -120.96M | -95.58M |
| Cash Acquisitions | -5.35B | -285.19M | ||||
| Sale (Purchase) of Intangibles | -13.10M | -7.94M | -1.99M | -10.92M | 92.74M | -23.65M |
| Investment in Securities | 730.11M | -18.07M | 222.77M | -3.63M | 8.19M | -246.09M |
| Other Investing Activities | 4.97M | 1.14M | -994.00K | |||
| Investing Cash Flow | -4.75B | -414.24M | 136.49M | -111.24M | -20.03M | -366.31M |
| Long-Term Debt Repaid | -494.99M | -3.04M | ||||
| Net Debt Issued (Repaid) | 3.65B | -494.99M | -3.04M | |||
| Issuance of Common Stock | 13.41M | 14.46M | 49.28M | 69.35M | 69.33M | 49.19M |
| Repurchase of Common Stock | -44.38M | -55.97M | -77.56M | -76.32M | -54.28M | -45.80M |
| Other Financing Activities | -66.49M | -889.00K | -3.18M | -11.76M | -33.70M | -398.00K |
| Financing Cash Flow | 3.55B | -42.39M | -526.45M | -18.73M | -18.65M | -48.00K |
| Foreign Exchange Rate Adjustments | 328.00K | -2.52M | 4.83M | 1.31M | 32.00K | -57.00K |
| Net Cash Flow | -339.81M | 368.84M | 187.72M | 30.60M | 137.25M | -61.88M |
| Free Cash Flow | 738.18M | 724.96M | 487.42M | 62.57M | 54.94M | 208.96M |
| Free Cash Flow Margin | 21.67% | 22.50% | 17.08% | 2.59% | 2.62% | 11.32% |
| Free Cash Flow Per Share | 3.76 | 3.67 | 2.48 | 0.33 | 0.29 | 1.14 |
| Levered Free Cash Flow | 85.16M | 402.66M | 212.05M | -17.35M | 137.32M | 201.61M |
| Unlevered Free Cash Flow | 137.41M | 409.47M | 219.97M | -6.52M | 147.30M | 211.19M |
| Cash Interest Paid | 7.32M | 7.25M | 10.36M | 10.30M | 10.28M | 10.39M |
| Cash Income Tax Paid | 87.32M | 96.20M | 57.27M | 73.31M | 54.37M | 18.15M |
| Change in Working Capital | -60.45M | -293.66M | -216.40M | -336.54M | -96.38M | 66.03M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 11.33B | 11.42B | 12.53B | 18.16B | 19.23B | 16.22B |
| Enterprise Value | 14.65B | 10.54B | 12.20B | 18.13B | 19.05B | 16.23B |
| Last Close Price | 58.51 | 59.43 | 65.73 | 96.42 | 103.49 | 88.35 |
| PE Ratio | 154.39 | 32.72 | 29.35 | 108.34 | 135.87 | |
| Forward PE | 12.88 | 12.37 | 17.86 | 38.98 | 39.00 | 85.78 |
| PS Ratio | 3.32 | 3.54 | 4.39 | 7.51 | 9.18 | 8.79 |
| PB Ratio | 1.79 | 1.88 | 2.21 | 3.67 | 4.18 | 3.80 |
| P/TBV Ratio | 14.40 | 2.05 | 2.44 | 4.10 | 4.73 | 4.41 |
| P/FCF Ratio | 15.34 | 15.75 | 25.70 | 290.28 | 350.06 | 77.63 |
| P/OCF Ratio | 13.21 | 13.79 | 21.87 | 114.04 | 109.34 | 53.26 |
| PEG Ratio | 0.44 | 0.65 | 0.72 | 1.07 | 0.86 | 2.66 |
| EV/Sales Ratio | 4.30 | 3.27 | 4.28 | 7.50 | 9.09 | 8.79 |
| EV/EBITDA Ratio | 22.71 | 14.59 | 21.38 | 62.49 | 121.62 | 481.22 |
| EV/EBIT Ratio | 29.32 | 16.20 | 25.73 | 97.60 | 348.42 | |
| EV/FCF Ratio | 19.85 | 14.54 | 25.03 | 289.80 | 346.74 | 77.67 |
| Debt / Equity Ratio | 0.67 | 0.11 | 0.11 | 0.23 | 0.24 | 0.26 |
| Debt / EBITDA Ratio | 6.41 | 0.88 | 1.08 | 3.73 | 6.58 | 23.56 |
| Debt / FCF Ratio | 5.69 | 0.89 | 1.30 | 18.12 | 20.38 | 5.38 |
| Net Debt / Equity Ratio | 0.53 | -0.15 | -0.09 | 0.01 | -0.04 | 0.03 |
| Net Debt / EBITDA Ratio | 5.16 | -1.27 | -0.88 | 0.21 | -1.10 | 3.25 |
| Net Debt / FCF Ratio | 4.51 | -1.27 | -1.03 | 0.96 | -3.12 | 0.52 |
| Asset Turnover | 0.35 | 0.44 | 0.41 | 0.37 | 0.34 | 0.31 |
| Inventory Turnover | 1.07 | 1.20 | 1.14 | 1.28 | 1.38 | 1.49 |
| Quick Ratio | 1.16 | 3.25 | 2.96 | 1.45 | 2.98 | 2.54 |
| Current Ratio | 2.39 | 5.21 | 5.33 | 2.51 | 4.67 | 4.16 |
| Return on Equity (ROE) | 1.18% | 5.94% | 8.05% | 3.51% | 3.19% | -1.53% |
| Return on Assets (ROA) | 3.26% | 5.58% | 4.29% | 1.76% | 0.55% | -0.78% |
| Return on Invested Capital (ROIC) | 3.24% | 9.12% | 7.35% | 3.50% | 1.18% | -1.74% |
| Return on Capital Employed (ROCE) | 5.00% | 9.50% | 7.40% | 3.30% | 0.90% | -1.40% |
| Earnings Yield | 0.65% | 3.06% | 3.41% | 0.92% | 0.74% | -0.40% |
| FCF Yield | 6.52% | 6.35% | 3.89% | 0.34% | 0.29% | 1.29% |
| Buyback Yield / Dilution | -0.61% | -0.35% | -2.67% | -1.39% | -3.34% | 4.61% |